Novartis Oncology Director, US Patient Engagement Karen is responsible for engaging with lung cancer patient groups and several other solid tumor patient communities to help drive the Novartis Patient Engagement vision of being the leading pharmaceutical company that consistently and systematically engages patients across the medicines lifecycle. (more ...) Karen fosters and maintains relationships with patient groups to identify and find ways to address common goals, gather patient and caregiver insights, and improve awareness, education and outcomes. Karen has been at Novartis for 13 years and in that time she has helped develop and train the global network of patient advocacy leads, convened patient advocates from around the world and from various disease communities for summits and best practice sharing, spearheaded collaborations with patient groups, engaged colleagues from various US and global functions to partner with the patient community and supported the work of numerous patient groups. Karen is a member of an internal workstream to address health equity barriers in clinical trials, has significant communications experience prior to and at Novartis and is passionate about addressing communications gaps. She was born and raised in New York City and received her BA in English from Georgetown University. HEC member category Industry
